Sustained whole-body functional rescue in congestive heart failure and muscular dystrophy hamsters by systemic gene transfer.
about
Disease rescue and increased lifespan in a model of cardiomyopathy and muscular dystrophy by combined AAV treatmentsPolymers for improving the in vivo transduction efficiency of AAV2 vectorsGait disturbances in dystrophic hamsters.Enhancing muscle membrane repair by gene delivery of MG53 ameliorates muscular dystrophy and heart failure in δ-Sarcoglycan-deficient hamsters.A myocardium tropic adeno-associated virus (AAV) evolved by DNA shuffling and in vivo selection.Heart-targeted adeno-associated viral vectors selected by in vivo biopanning of a random viral display peptide library.Limb-girdle muscular dystrophies: where next after six decades from the first proposal (Review).Fasting increases the in vivo gene delivery of AAV vectors.Gene and cell-mediated therapies for muscular dystrophy.Adeno-associated virus serotype-9 microdystrophin gene therapy ameliorates electrocardiographic abnormalities in mdx mice.Worsening of cardiomyopathy using deflazacort in an animal model rescued by gene therapy.Empowering adult stem cells for myocardial regenerationCardiac gene therapyRobust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8.A potential role of distinctively delayed blood clearance of recombinant adeno-associated virus serotype 9 in robust cardiac transduction.AAV vectors for cardiac gene transfer: experimental tools and clinical opportunities.Alpha-linolenic acid-enriched diet prevents myocardial damage and expands longevity in cardiomyopathic hamstersHigh intake of saturated fat, but not polyunsaturated fat, improves survival in heart failure despite persistent mitochondrial defects.Systemic gene transfer to skeletal muscle using reengineered AAV vectorsViral-mediated gene therapy for the muscular dystrophies: successes, limitations and recent advancesMarine n3 polyunsaturated fatty acids enhance resistance to mitochondrial permeability transition in heart failure but do not improve survival.Challenges and opportunities in dystrophin-deficient cardiomyopathy gene therapy.Creation of a cardiotropic adeno-associated virus: the story of viral directed evolution.Progress in gene therapy of dystrophic heart disease.Gene therapy in the treatment of heart failure.Efficient whole-body transduction with trans-splicing adeno-associated viral vectorsProspect of gene therapy for cardiomyopathy in hereditary muscular dystrophy.Delta-sarcoglycan gene therapy halts progression of cardiac dysfunction, improves respiratory failure, and prolongs life in myopathic hamstersGene doping: the hype and the reality.An emerging adeno-associated viral vector pipeline for cardiac gene therapyDesigning heart performance by gene transfer.Characterization of early pathogenesis in the SOD1(G93A) mouse model of ALS: part I, background and methods.K137R mutation on adeno-associated viral capsids had minimal effect on enhancing gene delivery in vivo.AAV-directed muscular dystrophy gene therapy.Cardiac gene therapy with SERCA2a: from bench to bedsideGene therapy for heart disease: molecular targets, vectors and modes of delivery to myocardium.Promise of adeno-associated virus as a gene therapy vector for cardiovascular diseases.Use of a lower dosage liver-detargeted AAV vector to prevent hamster muscular dystrophy.Gene-therapy delivery strategies in cardiology.Developmental Changes in the ECG of a Hamster Model of Muscular Dystrophy and Heart Failure.
P2860
Q27349992-727F89DE-D59A-4B9A-BA04-168F1ED38F75Q27438107-F4CD40BA-7B18-4C70-8F8F-51FE87343C88Q30498131-016E1512-9BE2-4EE8-8ED9-5C4AC54CB669Q30512833-BFBEEC54-E0C9-4744-A076-CC5E0C647CD1Q33411254-26143C89-7B62-47D5-A5CC-7371C1429AECQ33555864-A7B7F7B3-E64B-4D11-920D-E21ECE4D73A5Q33608787-BC8EE3CE-FD40-4A00-8F2C-040EA6ED380BQ33712847-8C0A89DB-71FB-4F0D-9333-C1A013609E21Q33831193-0E20DA20-C0E3-4A3A-98E6-0AF8065481C7Q33925312-E592794D-6C22-44A0-A6D5-99EA8D72221CQ34023992-E4DF02B1-8E5B-4E6B-89CF-9849982F6675Q34239856-3708D7B6-FCB1-4695-A7BB-BADE072CBE7FQ34409721-1AFA634E-0087-4CF5-8661-C3316BEC40ADQ35025591-60AAC001-0458-43A8-A5B3-6C0EDA454D9AQ35086706-E2EEA900-5EFB-424D-8A39-698B02017094Q35238264-1A06A94C-2A4D-4FE6-A7E9-CFB1CD9EF897Q35569816-7CC94F93-A14E-422B-9114-4CD5E8163A18Q35624662-B4FD4420-2A49-41F1-AF62-908086FAED2CQ35659639-E06CDA31-6E1F-4B13-81A6-64988A5DC40AQ35847178-EEF43C9D-19BD-4137-9FAE-1323AC379CE5Q36528123-B8B062DA-755E-421D-821B-8A671D9D2CEBQ36599311-E311C2EB-5940-404E-ACAA-6B2731F987C9Q36614445-F90BB5BA-68E7-4AB0-B88D-D2F2837CCF0BQ36773242-7C9EFCED-6F2D-4EBA-8C2C-31A348FD1BF5Q36786243-9371D1C2-8555-466B-8947-69FA1245A068Q36968872-B236BC1C-9922-4CCF-BEE6-7C990C600788Q37021623-AA162689-861A-477E-9BE2-053A2B344755Q37092093-58B8F064-9E74-4D27-BD4C-EEF0325A43FEQ37171838-FFD4EC44-069D-4D9E-B562-340001036665Q37272838-078862DC-EB5A-473D-B9B7-B00B39E306BEQ37299072-02BDA8CF-B5D5-43D1-B4E3-69AF8B64BEA7Q37407284-CDBADA19-C054-4BD8-B9E0-EEE3C5E660B9Q37524906-BF47FBCD-A842-4804-93A5-CB8C2DD567DFQ37687423-248D24B2-65DC-489C-945B-B236413DFDC6Q37811189-3AA897CC-0DCB-42CE-BDC8-4D4BF0D9CA15Q38132253-3F57E60B-4471-43CB-B504-68C4C68DEB2EQ39356341-E4702680-71B1-4235-9804-B5154B747246Q39962189-77C68B84-8EF3-44DE-A4B2-ABBE49A3132EQ40119187-C9EF7534-88E4-4C50-A6A5-7A7A2794BB6DQ41953299-78D4D6E3-5946-4F5E-8DD5-44B2BC4264F4
P2860
Sustained whole-body functional rescue in congestive heart failure and muscular dystrophy hamsters by systemic gene transfer.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Sustained whole-body functiona ...... ers by systemic gene transfer.
@en
Sustained whole-body functiona ...... ers by systemic gene transfer.
@nl
type
label
Sustained whole-body functiona ...... ers by systemic gene transfer.
@en
Sustained whole-body functiona ...... ers by systemic gene transfer.
@nl
prefLabel
Sustained whole-body functiona ...... ers by systemic gene transfer.
@en
Sustained whole-body functiona ...... ers by systemic gene transfer.
@nl
P2093
P1433
P1476
Sustained whole-body functiona ...... ers by systemic gene transfer.
@en
P2093
Charles F McTiernan
Chunlian Chen
Chunping Qiao
Dao Wen Wang
Liqiao Zhou
Satsuki Mori
Zhong Wang
P304
P356
10.1161/CIRCULATIONAHA.105.565598
P407
P577
2005-10-17T00:00:00Z